Global Virtual Congress

Community Oncology Global Congress 2026

Table of contents

Overview

Event Highlights

Uniting oncologists, care teams, researchers, advocates, and policymakers to advance cancer care beyond major academic centers.
Recognizing community practices as the first and most vital point of access for diagnosis, treatment, and ongoing care.
Giving experts from different regions a platform to share experiences, highlight barriers, and improve outcomes in their communities.

Date / Time

Aug 28, 2026 – Aug 30, 2026

DAY 3

Community Oncology Global Congress 2026 August 30, 2026. https://t.co/6r26c8t2pg

— OncoDaily (@oncodaily) August 30, 2026

DAY 2

Community Oncology Global Congress 2026 August 29, 2026. https://t.co/uPRGjxMjmC

— OncoDaily (@oncodaily) August 29, 2026

DAY 1

Community Oncology Global Congress 2026 https://t.co/H3jkC6fF60

— OncoDaily (@oncodaily) August 28, 2026

Scientific Leadership

Jasmine Kamboj Community Poster

Jasmine Kamboj MD FASCO – USA, Minnesota
Founder & CEO, Arogya Oncology & Hematology PLLC
Medical Director, CCIC NF Hospital + Clinics, Northfield, MN
Minnesota Society of Clinical Oncology, Board Member
American Society of Clinical Oncology, International Affairs Committee
OncoDaily, Podcast Host, “Empowering Oncologists”

Foluke Sarimiye Community Poster

Foluke Sarimiye, MD, MSc, FWACS – Nigeria
Lecturer, Department of Radiation Oncology, College of Medicine, University of Ibadan
Consultant Radiation & Clinical Oncologist, University College Hospital, Ibadan
Co-Founder & Executive Director, Patela Care Foundation
Financial Secretary, Association of Radiation and Clinical Oncologists of Nigeria (ARCON)
Chair, Education, Research & Training Committee, Psycho-Oncology Society of Nigeria (POSON)

Felipe Roitberg Community Poster

Felipe Roitberg, MD – Brazil
Medical Oncologist, Coordinator, Research, Innovation & Health Technology Assessment, Brazilian University Hospitals Network (Rede Ebserh)
Former Technical Officer for Cancer, World Health Organization (WHO), Ukraine
Former Cancer Control Consultant, World Health Organization (WHO) Headquarters, Geneva

Joanna Metzner-Sadurski Community Poster

Joanna Metzner-Sadurski, MD – USA, South Carolina
Director of Medical Oncology, Self Regional Healthcare
Medical Oncologist and Hematologist, Self Regional Healthcare Cancer Center
Founder & Executive Director, Oncology101.org
Member, ASCO Health Policy Committee

Amol Akhade Community Poster

Amol Akhade MD, DM – India
Senior Consultant, Medical Oncology, Fortis Hospital Mulund, Mumbai
Medical & Hemato-Oncologist, Fortis Hospitals Mumbai
DNB Faculty in Medical Oncology
Formerly trained in Medical Oncology & Hemato-Oncology, Tata Memorial Hospital, Mumbai

Robin Zon, MD, FACP, FASCO – USA, Ohio
Director of Breast Cancer Oncology, Cincinnati Cancer Advisors
Medical Oncologist, Cincinnati Cancer Advisors
Chair, Association for Clinical Oncology Board of Directors
Past President, American Society of Clinical Oncology (ASCO) Society Board of Directors
Former President & Physician Emeritus, Michiana Hematology Oncology

Debra Patt Community Poster

Debra A. Patt, MD, PhD, MBA, FASCO – USA, Texas
Executive Vice President, Policy and Strategy, Texas Oncology
Managing Partner, Texas Oncology
Medical Director for Public Policy, The US Oncology Network
President, Community Oncology Alliance (COA)
Board Member, American Society of Clinical Oncology (ASCO)
Clinical Professor, Dell Medical School, The University of Texas at Austin

Scientific Leadership

Jasmine Kamboj Community Poster

Foluke Sarimiye Community Poster

Felipe Roitberg Community Poster

Joanna Metzner-Sadurski Community Poster

Amol Akhade Community Poster

Debra Patt Community Poster

Speakers

Images	Name
	Janet L. Abrahm - USA, Massachusetts Professor of Medicine, Harvard Medical School Pioneer in supportive and palliative oncology Founder, Palliative Care Service, Dana-Farber Cancer Institute and Brigham and Women’s Hospital Author of Comprehensive Guide to Supportive and Palliative Care for Cancer Patients.
	Katie Alexander - USA, Ohio Adult-Gerontology Acute Care Nurse Practitioner specializing in adult oncology care Advanced Practice Provider Coordinator, American Oncology Network Oncology APP, Mark H. Zangmeister Cancer Center Focused on APP onboarding, education, and professional development.
	Alice Indini - Italy Medical Oncologist specializing in melanoma, cancer immunotherapy, and AYA oncology International melanoma researcher with over 100 peer-reviewed publications Focused on melanoma biology, immunotherapy response, survivorship care, and immune-related toxicities Involved in international oncology education, ESMO initiatives, and mentorship programs for young oncologists.
	Jeanine Frances Ewing - USA, Florida Board Certified Oncology Pharmacist that specializes in oncology formulary management, evidence-based pharmacy practice, and multidisciplinary cancer care Speaker and consultant in oncology pharmacy education, guideline development, and clinical decision support.
	Korede Akindele - Nigeria Chief Operating Officer, The Dorcas Cancer Foundation Global Child Health Leader, Health Systems Strategist, and Implementation Science Specialist Former Board Member, International Society of Paediatric Oncology Former Chair, Young SIOP Network Focused on childhood cancer control, early diagnosis, treatment access, survivorship, and health systems strengthening.
	Mohana Murali Kolluri - India Consultant Radiation Oncologist, Trinity Hospitals, Kakinada, India Specialist in advanced radiotherapy techniques, including IMRT, VMAT, IGRT, SBRT, and brachytherapy Focused on gastrointestinal and head and neck cancers, clinical research, cancer education, and evidence-based cancer awareness.
	Raghad Abdul Karim - USA, Texas Hematologist-Oncologist, NOVA Oncology Clinical researcher with contributions to over 60 clinical studies Focused on precision oncology, clinical trials, underserved communities, and patient-centered oncology care.
	Piotr Rutkowski - Poland Surgical Oncologist and Sarcoma/Melanoma Research Leader Head, Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw Leader in Surgical Oncology, Sarcoma, Melanoma, GIST, Clinical Trials, Precision Oncology, National Oncology Strategy, Cancer Research Leadership, and Multidisciplinary Cancer Care
	Ruiling Yuan - USA, South Carolina Board-certified Medical Oncologist and Hematologist, Self Regional Healthcare Dyad Director, Cancer Service Line, Self Regional Healthcare Clinical Assistant Professor, Medical University of South Carolina Board Member, South Carolina Oncology Society Representative, ASCO State Affiliate Council and ASCO PAC Advisory Council Focused on community and rural cancer care, health policy, survivorship, patient access, and health literacy.
	Vinona Bhatia - USA, California Vinona Bhatia Hematologist-Oncologist, Healthcare Operator, and Investor Founder, Partnering for Cancer Innovation Venture Partner, Cancer Fund Advisor and LP, How Women Invest and Coyote Ventures Focused on precision oncology, biomarker-driven care, health equity, clinical strategy, and cancer care innovation.
	Jenny Ahlstrom - USA, Utah Cancer Patient Advocate and Healthcare Innovation Leader Founder and Chief Executive Officer, HealthTree Foundation Leader in Multiple Myeloma Advocacy, Patient-Owned Health Data, Personalized Patient Education, Cancer Research Acceleration, Digital Health Innovation, Community Support, and Patient Empowerment
	Seema Harichand-Herdt - USA, Iowa Medical Oncologist and Hematologist, Mission Cancer + Blood Community Oncology Leader Focused on breast cancer care, clinical research, and patient-centered cancer care delivery.
	Lara Briseño Kenney - New Zealand Medical Oncologist and Hematologist, United States Founder, Leeton Medical Leader in rural oncology, hematology, palliative care, and community-based cancer care Focused on expanding access to direct specialty care and improving cancer care delivery in underserved settings.
	Jahan Aghalar - USA, New York Medical Oncologist and Hematologist, New York Cancer & Blood Specialists Leader in genitourinary oncology and community-based cancer care Focused on patient-centered hematology and oncology practice in the community setting.
	Reham Abdel-Wahab - United States, Ohio MD, PhD Medical Oncologist and Clinical-Translational Cancer Researcher Cleveland Clinic, Department of Cancer Sciences, Global Center for Immunotherapy and Precision Immuno-Oncology; Department of Hematology Oncology, Taussig Cancer Center; Research Secondment, Cleveland Clinic Abu Dhabi Cancer Institute Leader in Precision Oncology, Immunotherapy, Gastrointestinal Cancers, AI-Enabled Oncology Research, Real-World Cancer Care, Multi-Center Data and Biospecimen Platforms, and Global Oncology Research Collaboration
	Fernando Maciel Barbosa - USA, Iowa Medical Oncologist and Clinical Associate Professor, University of Iowa Health Care Specialist in genitourinary oncology, including prostate, bladder, and kidney cancers Focused on clinical research, cancer clinical trials, and equitable access to high-quality oncology care.
	Anjali Sibley - USA, California Medical Oncologist and Hematologist, Stanford Medicine Cancer Center in Emeryville Clinical Associate Professor of Medicine, Stanford School of Medicine Director, Stanford Medicine Cancer Center in Emeryville Leader in community-based oncology Focused on cancer survivorship, health equity, clinical trial access, and patient-centered cancer care.
	Adil Iqbal - India Senior Consultant Surgical Oncology Expert in gastrointestinal, breast, and thoracic cancers Specialist in complex cancer surgery and patient-centered surgical care.
	Sergio Contreras Garduño - Mexico Medical Oncologist, Mexico City, Mexico Specialist in solid tumors and hematologic malignancies Focused on evidence-based, patient-centered oncology and individualized treatment planning.
	Mark A. Walshauser - United States, Illinois Hematologist, Medical Oncologist, and Oncology Policy Leader Partner, Cancer Care Specialists of Illinois; Medical Director of Oncology, St. Elizabeth’s Hospital Leader in Community Oncology, Hematology and Medical Oncology, Oncology Policy, Coverage and Reimbursement, Clinical Practice Innovation, Cancer Advocacy, Clinical Trial Accrual, and Expanding Access to High-Quality Cancer Care
	Jose W. Avitia - USA, New Mexico Medical Oncologist and Hematologist, Albuquerque and Gallup, New Mexico Board-certified in Medical Oncology and Internal Medicine Focused on patient-centered cancer care in diverse and rural communities.
	Terri Conneran - USA, North Carolina Lung Cancer Survivor and Patient Advocate Advocate, KRAS Kickers Focused on KRAS-driven lung cancer awareness, education, community support, and research advocacy.
	Astriani Dwi Aryaningtyas - Indonesia Health advocate, psycho-oncology counselor, and cancer survivor. She is the founder of Inspirasien, a health advocacy platform that provides medical and psychological advocacy for patients and caregivers. She is also a founder of Pita Tosca, an Indonesian thyroid health patient organization.
	Allen Chen - USA, California MD, MBA, FASTRO, FACHE Physician-Scientist and Oncology Diagnostics Leader Vice President of Medical Affairs and Clinical Development, BillionToOne Leader in Translational Oncology, Next-Generation Cancer Diagnostics, Liquid Biopsy, Precision Oncology, Clinical Development, Medical Affairs, Healthcare Management, Value-based Cancer Care, Education, and Expanding Access to Oncology Innovation
	Kurt R. Oettel - USA, Wisconsin Medical oncologist based in La Crosse, Wisconsin, affiliated with Gundersen Lutheran Medical Center and Black River Memorial Hospital. He earned his medical degree from the University of Wisconsin School of Medicine and Public Health and has over 20 years of clinical experience. He specializes in the diagnosis and treatment of cancers including lung, breast, and prostate cancer, using systemic therapies such as chemotherapy and comprehensive oncology care.
	Astha Thakkar - USA, North Carolina Board-certified Hematologist-Oncologist Specialist in leukemia, lymphoma, and multiple myeloma Focused on patient-centered care and individualized treatment planning.
	Kashif Ali - USA, Maryland Board-certified Medical Oncologist and Hematologist, Maryland Oncology Hematology Specialist in gastrointestinal and pancreatic malignancies Focused on comprehensive inpatient and outpatient cancer care.
	Adedayo Joseph - Nigeria Clinical Radiation Oncologist, Healthcare Leader, and Cancer Equity Advocate Consultant Oncologist and Research Program Director, Medserve-LUTH Cancer Center; Adjunct Lecturer, College of Medicine, University of Lagos; Founder, The Dorcas Cancer Foundation Leader in Radiation Oncology, Lung, Brain and Pediatric Cancers, Clinical Trials, Oncology Education, Capacity Building, Health Systems Strengthening, Childhood and Adolescent Cancer Care, and Equitable Access to Cancer Services across Africa
	Adrian Pogacian - Romania Licensed clinical psychologist with advanced training in psycho-oncology. Founder of INCKA Psycho-Oncology Center, his expertise is in Coping with Cancer, Complicated Grief, Posttraumatic Growth and Meaning-Centered therapy approach.
	Kashyap Patel - USA, South Carolina Medical Oncologist and Community Oncology Leader Chief Executive Officer, Carolina Blood and Cancer Care Associates; Associate Professor of Medicine, Edward Via College of Osteopathic Medicine Leader in Community Oncology, Value-Based Cancer Care, Healthcare Policy, Cancer Health Disparities, Precision Medicine, Oncology Practice Leadership, and Equitable Access to Cancer Care
	Kathy Oubre - USA, California CEO, Pontchartrain Cancer Center Board Member, Community Oncology Alliance Co-chair, COA Drug Policy and Regulatory Affairs Committee Co-chair, Association of Value-Based Cancer Care and NCODA Oncology Institute Associate Editor, Evidence-Based Oncology Focused on community oncology leadership, value-based cancer care, drug policy, regulatory affairs, and government affairs.
	Anezka Ferrari - Brazil Clinical Oncologist, Brazil Medical Oncologist, DASA Oncology – Hospital Santa Paula, São Paulo Leader in Breast Cancer Care, Clinical Oncology, Cancer Diagnosis and Treatment, Patient-Centered Oncology Practice, and Cancer Education.
	Jack Hensold - USA, Montana Hematologist and Medical Oncologist, United States Retired Physician, Bozeman Health Cancer Center; President, Montana State Oncology Society Leader in Rural Oncology, Community-Based Cancer Care, Hematology, Medical Oncology, Cancer Care Delivery, and Access to Quality Cancer Care in Rural Communities.
	Clement Adebamowo - USA Cancer Epidemiologist and Global Oncology Researcher, United States / Nigeria Professor and Director, Cancer Epidemiology Division, University of Maryland School of Medicine Leader in Cancer Epidemiology, Global Oncology, Cancer Prevention, Genomics Research, Bioethics, and Cancer Control.
	Fredrick Chite Asirwa - Kenya Medical Oncologist and Hematologist, Kenya Chief Executive Officer, International Cancer Institute Leader in Global Oncology, Cancer Research, Clinical Trials, Oncology Education, Early Detection, Cancer Care Access, and Capacity Building across Sub-Saharan Africa.
	Anastasia Danilova - Russia Medical Oncologist, Russia Medical Oncologist, Moscow Comprehensive Cancer Centre 62 Leader in Breast Cancer, Lung Cancer, Real-World Oncology Research, Clinical Data, Immuno-Oncology, and Patient-Centered Cancer Care
	Atlal Abusanad - Saudi Arabia Medical Oncologist and Hematologist, Saudi Arabia Professor of Medicine and Medical Oncology, King Abdulaziz University Leader in Breast Cancer Care, Molecular Oncology, Survivorship, Oncology Workforce Wellbeing, Clinical Research, and Cancer Care Access in the Gulf Region
	Muhamad Alhaj Moustafa - USA, Florida Hematologist and Medical Oncologist, United States Assistant Professor of Medicine, Mayo Clinic College of Medicine and Science; Consultant in Hematology/Oncology, Mayo Clinic Florida Leader in Lymphoma, Rare Hematologic Malignancies, Clinical Trials, Cellular Therapies, Precision Medicine, Medical Education, and Multidisciplinary Cancer Care
	Josue J. Bravo Espinoza - Peru Medical Oncologist, Clínica Oncosalud, AUNA Leader in Medical Oncology, Oncology Care in Conflict-Affected Settings, Resource-Constrained Cancer Care, Molecular Oncology, Oncology Research and Education, and Expanding Access to High-Quality Cancer Care in Complex Environments
	Pranshu Bansal - USA, Arizona Medical Oncologist, United States Director, Thoracic, Head & Neck Oncology, Ironwood Cancer & Research Center Leader in Thoracic Oncology, Lung Cancer, Head and Neck Cancer, Clinical Research, Investigational Therapies, and Community-Based Cancer Care.
	Brian Grieb - USA, Tennessee Medical Oncologist, United States Director of GI Malignancy Research, Tennessee Oncology Leader in Gastrointestinal Oncology, Community-Based Cancer Care, Phase II and III Clinical Trials, Clinical Research Access, Translational Cancer Biology, and Rural Oncology Care
	Amitabh Ray - India Radiation Oncologist, India Professor and Senior Consultant in Radiation Oncology, Chittaranjan National Cancer Institute Leader in Radiation Oncology, Thoracic and Genitourinary Cancers, Advanced Radiotherapy, Multidisciplinary Cancer Care, Oncology Education, and Equitable Access to Cancer Care
	Benda Kithaka - Kenya Cancer Advocate and Health Strategist, Kenya Founder and Executive Director, KILELE Health Association; Secretariat Lead, African Cervical Health Alliance Leader in Cervical Cancer Elimination, Patient Advocacy, Policy Influence, Community Mobilization, Strategic Communication, and Equitable Cancer Control across Africa
	Irene Chidothe-Chisale - Malawi Clinical and Radiation Oncologist, Malawi Chief Clinical and Radiation Oncologist, Malawi National Cancer Centre; Clinical Lecturer, Kamuzu University of Health Sciences Leader in Radiation Oncology, Genitourinary Cancers, Breast, Pediatric and Hematologic Cancer Care, Global Oncology, Capacity Building, and Equitable Cancer Care in Resource-Constrained Settings
	Devika Das - USA, Mississippi Thoracic Medical Oncologist, United States Associate Director for Clinical Affairs, Cancer Institute at the University of Mississippi Leader in Thoracic Oncology, Lung Cancer Screening, Cancer Program Development, Quality and Safety, Clinical Trial Access, Community Oncology, and Equitable Patient-Centered Cancer Care
	Soham Banerjee - India Senior Consultant Genetic Counselor and Medical Geneticist, India Founder and Chairman, S B Genomics & Healthcare Solution; Head, Department of Medical Genetics and Genetic Counselling, Sharanya Super Speciality Hospital Leader in Genetic Counseling, Medical Genetics, Cancer Genetics, Rare Disease Advocacy, Rural Health Outreach, Genetic Education, and Community-Based Precision Healthcare
	Abena Yeboah Aduse-Poku - Ghana Belfast Clinical Oncologist, Ghana Directorate of Oncology, Komfo Anokye Teaching Hospital Leader in Breast, Gynecologic, Colorectal and Pediatric Cancer Care, Radiotherapy Delivery, Patient-Reported Outcomes, Oncology Education, Capacity Building, and Equitable Cancer Care in Resource-Limited Settings.
	Sola Adeleke - United Kingdom Post-CCT Clinical Oncologist and Clinician-Scientist, United Kingdom Post-CCT in Clinical Oncology, Guy’s and St Thomas’ NHS Foundation Trust; Founder and Chief Medical Officer, Curenetics Leader in Prostate Cancer, Radiotherapy, Medical Imaging, Health AI, Cancer Treatment Response Prediction, Oncology Innovation, and Improving Access to Oncology Care in Low-Resource Settings
	Vijay C - India BA, MSc, MPhil, Diploma in Narrative Practices, CCPC Psycho-Oncologist Psycho-Oncologist, Manipal Hospice and Respite Centre, MAHE Leader in Psycho-Oncology, Psychosocial Cancer Care, Palliative Care, Pediatric Psychosocial Care, Narrative Practices, Quality of Life Research, and Person-Centered Support for Patients and Families
	Martha Raymond - United States, Massachusetts / New York GI Cancer Advocacy and Patient-Reported Outcomes Leader Founder and CEO, GI Cancers Alliance; Founder and CEO, The Raymond Foundation Leader in Gastrointestinal Cancer Advocacy, Patient and Caregiver Advocacy, Patient-Reported Outcomes Research, Patient Education, Professional Facilitation, Oncology Program Development, and Amplifying the Patient Voice across the Cancer Care Continuum
	Roupen Odabashian - USA, Michigan Medical oncologist at Abbotsford Regional Hospital and the Founder of Meducation. AI. His work focuses on medical oncology, solid tumor care, precision oncology, artificial intelligence in oncology, medical education.
	Zaid Abdel Rahman - Jordan MD Hematologist, Stem Cell Transplant and Cellular Therapies Physician Hematology/Oncology, King Hussein Cancer Center Leader in Hematologic Malignancies, Hematopoietic Stem Cell Transplantation, Cellular Therapies, CAR-T Cell Therapy, Point-of-Care Manufacturing, Advanced Diagnostics, Immunotherapy, and Expanding Access to Novel Cancer Therapies in Resource-Limited Settings
	Ilya Tsimafeyeu - Russia / USA Medical Oncologist and Clinical Researcher Director, Bureau for Cancer Research (BUCARE) Leader in Genitourinary Oncology, Translational Research, Precision Oncology, Targeted Therapies, Immunotherapy, Biomarker-Driven Clinical Trials, Drug Development, and Global Oncology Collaboration
	Brian Bourbeau - USA, Virginia Oncology Practice Health and Care Delivery Leader Vice President of Care Delivery, American Society of Clinical Oncology Leader in Oncology Practice Operations, Cancer Care Delivery, Quality Improvement, Payment Reform, Value-Based Oncology, Practice Health, and Access to High-Quality Cancer Care
	Houda Belfekih - Tunisia Medical Oncologist, Educator, and Clinical Researcher Associate Professor of Medical Oncology, Faculty of Medicine of Tunis; Head, Department of Medical Oncology, Mohamed Taher Maamouri Hospital Leader in Medical Oncology, Geriatric Oncology, Multidisciplinary Cancer Care, Evidence-Based Oncology, Clinical Research, Medical Education, Quality Cancer Care Delivery, and Improving Care for Older Adults with Cancer
	Sana Al-Sukhun - Jordan Medical Oncologist and Hematologist Director, Al Hyatt Oncology Practice; Adjunct Professor of Medical Oncology Leader in Breast Cancer, Global Oncology, Resource-Stratified Cancer Care, Medical Oncology Education, Health Equity, and Cancer Care Delivery in Low-Resource Settings
	Yüksel Ürün - Turkiye Medical Oncologist Professor of Medicine, Department of Medical Oncology, Ankara University School of Medicine Leader in Genitourinary Oncology, Prostate Cancer, Kidney Cancer, Testicular Cancer, Clinical Research, Real-World Evidence, Treatment Outcomes, and Medical Oncology Education
	Deepak Paudel - Nepal Head and Neck Oncosurgeon and Reconstructive Surgery Specialist Associate Professor, Department of Otorhinolaryngology–Head and Neck Surgery, BP Koirala Institute of Health Sciences Leader in Head and Neck Surgical Oncology, Microvascular Reconstruction, Thyroid and Salivary Gland Surgery, Quality of Life Research, Functional Outcomes, Early Detection, and Head and Neck Cancer Screening
	Otavio Al-Alam - Brazil Medical Oncologist specializing in Gynecologic Oncology Head of Phase I Clinical Trials, Hospital Moinhos de Vento Leader in Gynecologic Oncology, Ovarian Cancer, Phase I Clinical Research, Precision Oncology, Cancer Immunotherapy, and Translational Cancer Research
	Wajeeha Aiman - USA, New York Hematology and Medical Oncology Fellow Roswell Park Comprehensive Cancer Center Emerging leader in Hematologic Oncology, Medical Oncology, Clinical Research, Cancer Treatment Outcomes and Evidence-Based Cancer Care
	Viviane Basílio - Brazil Clinical Oncologist at Oncologia D'Or Clinical Oncology Fellowship at A.C. Camargo Cancer Center Thoracic Oncology Care, Central Nervous System (CNS) Tumors, Uro-Oncology, Healthcare Disparities, Oncogeriatrics, and Palliative Care
	Christine Pfaff - USA, Ohio Oncology Pharmacy and Community Oncology Leader Director of Clinical Initiatives, Community Oncology Alliance Leader in Community Oncology, Medically Integrated Pharmacy, Clinical Operations, Payment Reform, Practice Support, Oncology Education, and Access to Cancer Care Close to Home
	Muna Al-Khaifi - Canada GP Oncologist, Breast Diagnostics and Cancer Survivorship Care, Department of Surgery, Mount Sinai Hospital; Assistant Professor, Department of Family and Community Medicine, University of Toronto; Cancer Survivorship & OncoMenopause Specialist; Leader in Breast Cancer Survivorship, Women’s Health, Patient-Centered Oncology Care, Digital Health, Oncology Education, and Cancer Survivorship Research
	Debanjan Kundu - India Clinical and Radiation Oncologist, Senior Resident in Radiation Oncology, Chittaranjan National Cancer Institute, Kolkata Leader in Precision Radiotherapy, SABR/SBRT, Adaptive Brachytherapy, Oligometastatic Disease, Radio-Immunotherapy, AI and Radiomics in Radiotherapy, and Cancer Care Delivery in Resource-Constrained Settings
	Iyad Sultan - Jordan MD Pediatric Hematologist-Oncologist and AI Healthcare Leader Chief Artificial Intelligence Officer, King Hussein Cancer Center; Founder and Head, AI & Data Innovation Office; Clinical Professor of Pediatrics, University of Jordan Leader in Pediatric Oncology, Artificial Intelligence in Cancer Care, Cancer Care Informatics, Large Language Models in Clinical Practice, Pediatric Cancer Epidemiology, Data Innovation, and Digital Transformation in Oncology
	Darshil Shah - USA, Arizona Medical Oncologist \| Director of GI Oncology, Ironwood Cancer & Research Centers \| Leader in Gastrointestinal Oncology, Community-Based Cancer Care, Phase II & III Clinical Trials \| Educator, Speaker, and Advisor
	Benjamin Bleiberg - USA, Pennsylvania Thoracic Medical Oncologist Hematology and Oncology Fellowship, University of Pennsylvania Leader in Thoracic Oncology, Clinical Trials, Real-World Evidence, Liquid Biopsy, Immunotherapy, Targeted Therapies, Biomarker Research, and Precision Cancer Care
	Ruby Arora - USA, Illinois Resident Physician PGY-3 Internal Medicine Resident, University of Illinois Chicago Emerging leader in Malignant Hematology, Lymphoma Clinical Research, Healthcare Disparities, Patient Advocacy, and Improving Cancer Care for Underserved Communities
	Nicola Fusco - Italy Professor of Pathology and Molecular Pathologist Full Professor of Pathology, University of Milan; Director, Division of Pathology and Somatic Molecular Diagnostics, European Institute of Oncology Leader in Molecular Pathology, Breast Cancer Diagnostics, Digital Pathology, Artificial Intelligence in Healthcare, Liquid Biopsy, Precision Oncology, and Translational Cancer Research
	Manojkumar Bupathi - USA, Colorado Medical Oncologist President, Rocky Mountain Cancer Centers Leader in Genitourinary Oncology, Kidney, Bladder, Prostate and Testicular Cancers, Community-Based Cancer Care, Clinical Research, Health Equity, and Oncology Practice Leadership
	Esther G. Chong - USA, Oregon Medical Oncologist and Breast Cancer Specialist Assistant Professor, Knight Cancer Institute, Oregon Health & Science University Leader in Breast Cancer Care, Cancer Survivorship, Long-Term Treatment Outcomes, Quality of Life, and Patient-Centered Oncology Care
	Glenn Balasky - USA, Colorado Community Oncology Executive and Practice Operations Leader Executive Director, Rocky Mountain Cancer Centers Leader in Community Oncology, Practice Management, Value-Based Cancer Care, Oncology Payment Reform, Patient Access, Healthcare Policy, and Cancer Care Delivery
	Martina Carullo - Italy Medical Oncologist and Oncology PhD Candidate University of Pisa; Colorectal Cancer Unit, University Hospital of Pisa Emerging Leader in Gastrointestinal Oncology, Colorectal Cancer, Translational Research, Immunotherapy, Liquid Biopsy, AI-Powered Biomarkers, and Precision Oncology
	Linda Bosserman - USA, California Medical Oncologist and Breast Cancer Specialist Professor, Department of Medical Oncology & Therapeutics Research; Medical Director, Value-Based Care and Center for International Medicine, City of Hope Leader in Breast Cancer, Sexual Health in Cancer Care, Oncology Pathways, Value-Based Care, International Oncology, Survivorship, and Patient-Centered Cancer Care
	Malu Barbosa - Canada/Brazil Medical Oncologist Medical Oncology Clinical Fellow, Sunnybrook Health Sciences Centre; University of Toronto Emerging Leader in Thoracic Oncology, Lung Cancer, Immunotherapy, Clinical Research, Real-World Evidence, Precision Oncology, and International Oncology Collaboration
	Mohamed Alsharedi - USA, Kentucky Hematologist and Medical Oncologist Hematology/Oncology, Markey Cancer Center at Lexington Clinic Leader in Hematology, Medical Oncology, Community-Based Cancer Care, Multidisciplinary Oncology, and Access to Advanced Cancer Treatment in Kentucky
	Simon Blanc- USA, Florida Hematologist and Medical Oncologist Cancer Center Director, Broward Health Leader in Community Oncology, Hematologic and Solid Tumor Malignancies, Precision Oncology, Real-World Evidence, Clinical Research, Health Equity, and Access to Advanced Cancer Care
	Brooke Peters - USA, Ohio PharmD, BCOP Clinical Pharmacist Clinical Pharmacist, American Oncology Network Leader in Oncology Pharmacy, Clinical Pharmacy Services, Hematology/Oncology Pharmacy Practice, Community Oncology, Medication Management, and Patient-Centered Cancer Care
	Victor Chiu - USA, Arizona Hematologist and Medical Oncologist Assistant Chief Medical Officer, Ironwood Cancer & Research Centers Leader in Breast Oncology, Skin Cancer, Sarcoma, Hematologic Disorders, Precision Medicine, Immunotherapy, Clinical Trials, and Community-Based Cancer Care
	Christine Verini - USA, New York Cancer Patient Advocacy and Nonprofit Healthcare Executive Chief Executive Officer, CancerCare Leader in Cancer Patient Support, Patient Advocacy, Psychosocial Oncology Services, Health Equity, Nonprofit Leadership, Mission-Based Programs, and Access to Cancer Care
	Melissa Johnson - USA, Tennessee MD Medical Oncologist and Lung Cancer Research Leader Chief Scientific Officer, SCRI; Director, Lung Cancer Research; Medical Oncologist, SCRI Oncology Partners Leader in Lung Cancer, Clinical Trials, Early Phase Drug Development, Immune Effector Cell Therapies, Oncology Research Strategy, and Advancing Cancer Care through Clinical Research
	Jonathan Ticku - USA, Wisconsin Hematologist and Medical Oncologist Assistant Professor of Oncology and GU Oncology Lead, Mayo Clinic Health System Leader in Community and Rural Oncology, Genitourinary and Thoracic Oncology, Hematologic Malignancies, Breast Cancer Care, Virtual Oncology, and Access to Advanced Cancer Therapies Close to Home
	Michael Crosby - USA, California Prostate Cancer Advocate and Patient Education Leader Ambassador and Board Member, Oncidium Foundation USA; Founder and CEO, Veterans Prostate Cancer Awareness Leader in Prostate Cancer Advocacy, Veteran Health, Patient Education, Molecular Imaging, Nuclear Medicine, Radioligand Therapy Awareness, and Access to Precision Cancer Care
	Oluseyi Abidoye - USA, Arizona Hematology and Medical Oncology Fellow Mayo Clinic Comprehensive Cancer Center, Phoenix Emerging Leader in Gastrointestinal Oncology, Precision Oncology, Liquid Biopsy, Biomarker-Driven Research, Clinical Trials, and Evidence-Based Cancer Care
	Qasim Mahmood Buttar - Pakistan Medical Oncologist Professor of Medical Oncology, Pakistan Institute of Medical Sciences; Consultant Medical Oncologist, Kulsum International Hospital Leader in Medical Oncology, Hematologic Malignancies, Solid Tumor Care, Clinical Research, Community-Based Oncology, and Cancer Care Delivery in Resource-Constrained Settings
	Mihran H. Shirinian - USA, California MD Hematologist and Medical Oncologist Comprehensive Hematology Oncology Centers; Glendale Adventist Medical Center; White Memorial Medical Center Cancer Services Leader in Community Oncology, Hematology, Medical Oncology, Clinical Trials, Head and Neck Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, and Patient-Centered Cancer Care
	Marc Braunstein - USA, New York Hematologist and Medical Oncologist Associate Professor of Medicine, NYU Grossman Long Island School of Medicine; Program Director, Hematology/Oncology Fellowship; Co-Director, Hematology Organ System; Vice President, Faculty Council Leader in Multiple Myeloma, Plasma Cell Disorders, Amyloidosis, Hematologic Malignancies, Stem Cell Transplantation, CAR T-Cell Therapy, Clinical Trials, and Personalized Hematologic Cancer Care.
	Noha Rashad - Egypt Medical Oncologist Medical Oncology Department, Suez University; Medical Oncology Consultant and Chair, Gastrointestinal Malignancies Interest Group, Shefa Al-Orman Comprehensive Cancer Center and Hospital Leader in Gastrointestinal Oncology, Neuroendocrine Tumors, Cancer Screening and Early Detection, Colorectal Cancer, Clinical Research, Critical Appraisal, and Cancer Care in Egypt
	Imène Hadji - Algeria Medical Oncologist and Global Oncology Advocate Medical Oncologist, Department of Medical Oncology, EPH Ain El Berda, Annaba; Lead, OncoDaily Algeria Hub Leader in Global Oncology, Equitable Cancer Care, Oncology Capacity Building, Real-World Cancer Research, Health Disparities, International Collaboration, and Oncology Education in Resource-Limited Settings
	Ala Ebaid - USA, New Mexico MD Hematologist and Classical Hematology Specialist Associate Professor, University of New Mexico School of Medicine; Director, Classical Hematology Program, UNM Comprehensive Cancer Center Leader in Classical Hematology, Myeloproliferative Neoplasms, Cancer-Associated Thrombosis, Thrombosis Research, Systemic Mastocytosis, and Hematology Program Development
	Fred Ashbury - USA, Colorado BA, MA, PhD, FMASCC Cancer Care Researcher and Supportive Oncology Leader Chief Scientific Officer, VieCure; Adjunct Professor, University of Calgary and The Ohio State University; Editor-in-Chief, Supportive Care in Cancer Leader in Supportive and Psychosocial Oncology, Cancer Care Quality, Clinical Guidelines, Oncology Research, Evidence-Based Practice, and Patient-Centered Cancer Care
	Angelina Lorello - USA, New York Patient Experience and Community Oncology Advocate Patient Experience, New York Cancer & Blood Specialists; CPAN Leader; Leader, Patient and Family Council Advocate whose personal story with community oncology inspires her work in patient experience, storytelling, and amplifying patient and caregiver voices
	Ahmed H. Abdelaziz - Egypt MSc, MD Clinical Oncologist and Breast Cancer Specialist Associate Professor, Ain Shams University Hospitals; Member, Supreme Committee for the Egyptian National Breast Cancer Programme Leader in Breast Cancer, Clinical Oncology, Cancer Care Quality, Public Sector Oncology, Clinical Governance, and Improving Cancer Care Delivery in Egypt
	Tuat Huynh - Vietnam MD, MSc Medical Oncologist and Clinical Researcher Medical Oncology Department, Oncology Center, Hue Central Hospital Leader in Head and Neck Cancer, Urogynecologic Cancers, Hepatobiliary-Pancreatic Cancers, Digital Oncology, AI in Oncology, Radiomics Research, Early Clinical Trials, and Advancing Cancer Care in Vietnam
	Gustavo Fonseca - USA, Florida MD, FACP Hematologist, Medical Oncologist, and Clinical Research Leader Director, Research and Clinical Trials, Florida Cancer Specialists & Research Institute Leader in Community Oncology, Hematology, Medical Oncology, Clinical Trials, Cancer Research, Patient-Centered Care, and Expanding Access to Oncology Innovation
	Rajani Jha - Nepal MD Medical Oncologist Assistant Professor of Medical Oncology, Patan Academy of Health Sciences; Consultant Medical Oncologist, Kathmandu Cancer Center Leader in Solid Tumor and Hematologic Cancer Care, Resource-Stratified Oncology, Precision Oncology, Cancer Education, Clinical Research, Financial Toxicity, Multidisciplinary Cancer Care, and Improving Access to Quality Oncology Care in Resource-Constrained Settings
	Irene Nzamu - Kenya MBS, MBChB, MMED, FPHO Pediatric Hematologist-Oncologist and Health Systems Leader Consultant Pediatric Hematologist-Oncologist, Kenyatta National Hospital; University of Nairobi Leader in Childhood Cancer Care, Pediatric Hematology-Oncology, Health Systems Strengthening, Early Diagnosis, Timely Referral, Equitable Treatment Access, Multidisciplinary Care, Survivorship, and Pediatric Oncology Capacity Building across Africa
	Alti Rahman - USA, Florida MBA, MHA, Certified Six Sigma Black Belt Healthcare Strategy, Innovation, and Community Oncology Leader Chief Strategy and Innovation Officer, American Oncology Network Leader in Community Oncology, Healthcare Innovation, Value-Based Care, Practice Operations, Quality Improvement, Cost Optimization, Multidisciplinary Care, and Patient-Centered Oncology Delivery
	Karez Sarbast Namiq - Iraq MD, MSc European School of Oncology graduate, with international certifications in breast cancer (ESO/Ulm University), palliative care (ESMO), and oncology nutrition (ONC). A published researcher and journal reviewer, she is a regular contributor to international oncology conferences and an active mentor to emerging oncology professionals.
	Sudharshan Gupta - India Radiation Oncologist Associate Consultant, Sahyadri Narayana Multispecialty Hospital, Shimoga, Karnataka Leader in Radiation Oncology, IMRT, IGRT, SRS, SBRT, TMLI, TBI, Brachytherapy, Multidisciplinary Cancer Treatment, and Neoadjuvant, Adjuvant, Radical, and Palliative Cancer Care
	Soumen Das - India Breast Surgical Oncologist Director, Institute of Breast Diseases, NCRI Hospital, Kolkata Leader in Breast Cancer Surgery, Breast Cancer Guidelines, Early Detection, Survivor-Led Patient Navigation, Cancer Care Equity, Low-Resource Oncology, Medical Education, and Improving Access to Breast Cancer Care in LMICs
	Carlos Barrios - Brazil Director, Oncology Research Center, Hospital São Lucas, PUCRS, Porto Alegre, Brazil. President, Latin American Cooperative Group, LACOG, Porto Alegre, Brazil.
	Hadi Mohamad Abu Rasheed - Qatar Cancer Education, Research, and Public Health Oncology Leader Scientific Advisor, Qatar Cancer Society; Adjunct Lecturer, University of Doha for Science and Technology Leader in Cancer Awareness, Professional Development, Cancer Education, Public Health, Early Detection, Research, Regional Oncology Collaboration, and Improving Access to Cancer Care
	Zacharoula Sidiropoulou - Portugal Breast Surgical Oncologist and Global Health Advocate Senior Consultant Breast Surgical Oncologist, Hospital São Francisco Xavier Leader in Breast Surgical Oncology, People-Centered Cancer Care, Global Health Equity, Surgical Workforce Development, Oncology Education, Multidisciplinary Cancer Care, and Advancing Equitable Access to Quality Cancer Care
	Arturo Loaiza-Bonilla - United States, Pennsylvania / New Jersey Physician-Scientist, AI Oncology Executive, and Hematologist/Medical Oncologist Co-Founder and Chief Medical AI Officer, Massive Bio; Systemwide Chief of Hematology and Medical Oncology, St. Luke’s University Health Network Leader in AI-Driven Precision Oncology, Clinical Trial Matching, Hematology and Medical Oncology, Biomarker-Driven Cancer Care, Immunotherapy, Clinical Research Infrastructure, Digital Oncology, and Translating Innovation into Patient Impact
	Suman S. Karanth - India Medical Oncologist Additional Director, Medical Oncology, Fortis Memorial Research Institute, Gurugram Leader in Gynaecological Oncology, Neuro-Oncology, Colorectal Cancer, Breast Cancer, Clinical Trials, Research Leadership, International Collaboration, and Bridging Cancer Care across Healthcare Systems

About the Congress

The congress is designed to highlight the essential role of community oncology in improving access, quality, equity, and continuity of cancer care. Through expert-led sessions, regional perspectives, and multidisciplinary discussions, the program will explore how community-based cancer care can be strengthened across diverse healthcare environments.

The event will focus on practical topics that directly affect oncology professionals and patients, including access to timely diagnosis, treatment delivery, patient navigation, multidisciplinary collaboration, workforce development, survivorship care, palliative care, cancer prevention, and the use of digital tools in community oncology.

By bringing together experts from different countries and healthcare systems, the congress aims to encourage meaningful dialogue and support the development of adaptable solutions that can improve cancer care in community settings worldwide.

Who Should Attend?

This congress is designed for community oncologists, medical oncologists, hematologists, radiation oncologists, surgical oncologists, oncology nurses, oncology pharmacists, palliative care professionals, patient advocates, healthcare administrators, researchers, policymakers, representatives of cancer organizations, and all professionals involved in improving cancer care delivery in community settings.

Why To Attend?

The Community Oncology Global Congress 2026 will provide a platform for international experts and frontline oncology professionals to discuss how cancer care is delivered outside major academic centers and how community-based care can be strengthened.

Participants will gain practical insights from diverse regions, learn from real-world experiences, and join a global conversation focused on improving access, quality, equity, and outcomes for patients with cancer.

Agenda

Date and Time	Topics and Speakers
Global Community Oncology: Access, Systems and Innovation
08:00– 08:15 CEST	Opening Remarks: Why Community Oncology Needs a Global Stage Opening remarks: Jasmine Kamboj (USA, Minnesota; local: 01:00–01:15 CDT) — with OncoDaily leadership Session topics: Congress leadership sets the premise for the three days: community practice treats the overwhelming majority of the world's cancer patients and is represented in almost none of the forums where cancer care is decided.
08:15–08:45 CEST	Community Oncology at the Center of Cancer Care: Why Is It Still Underrepresented? Moderator / chair: To be confirmed Presenter: Foluke Sarimiye (Nigeria; local: 07:15–07:45 WAT) — The Global Role of Community Oncology Presenter: Amol Akhade (India; local: 11:45–12:15 IST) — The Biggest Challenges Facing Community Oncology Today Presenter: Benda Kithaka (Kenya; local: 09:15–09:45 EAT) — The Future of Community Oncology
08:45–09:45 CEST	Precision Oncology in Community Practice: Building Sustainable Models of Care Moderator / chair: Suman Karanth Presenter: Atlal Abusanad (Saudi Arabia; local: 09:45–10:45 +03) — Building a Precision Oncology Programme in Community Practice — Community oncologist running a functioning local precision programme Presenter: Gc. Soham Banerjee (India; local: 12:15–13:15 IST) — Molecular Tumour Boards: Turning Genomic Results into Clinical Decisions — Molecular tumor board chair or clinical geneticist Genetic counsellor: Gc. Soham Banerjee (India; local: 12:15–13:15 IST) Molecular tumour board / community-academic perspective: Anastasia Danilova (Russia; local: 09:45–10:45 MSK) Session topics: • Connecting Community and Academic Oncology: Models for Sustainable Precision Care
09:45–10:45 CEST	Access Beyond Approval: Why Do European Patients Still Face Unequal Cancer Care? Moderator / chair: To be confirmed Presenter: Sola Adeleke (United Kingdom; local: 08:45–09:45 BST) — Community Oncology in Western Europe: Advancing Quality, Innovation and Integrated Care Presenter: Anastasia Danilova (Russia; local: 10:45–11:45 MSK) — Community Oncology in Central and Eastern Europe: Delivering High-Quality Care with Limited Resources Session topics: • Bridging Europe's Cancer Care Gap: From Approval to Equitable Access
10:45–11:45 CEST	Building Cancer Care Where the System Isn't Built Yet: What Actually Works Across Africa and the Middle East? Moderator / chair: Imène Hadji Presenter: Fredrick Chite Asirwa (Kenya; local: 11:45–12:45 EAT) — Building Sustainable Community Oncology in Resource-Limited Settings Presenter: Imene Hadji (Algeria; local: 09:45–10:45 CET) — Improving Access to Essential Cancer Services Presenter: Clement Adebamowo — Delivering Cancer Care in Challenging Environments Additional panellist: Atlal Abusanad Additional panellist: Foluke Sarimiye
12:00–12:30 CEST	Scaling Community Oncology Across Asia-Pacific: Innovation, Workforce and Access Format: Standalone presentation + Q&A Moderator / chair: Amol Akhade (India; local: 15:30–16:00 IST) Presenter: Mohana Murali Kolluri (India; local: 15:30–16:00 IST) — Delivering High-Quality Community Oncology in High-Volume Health Systems Session topics: • Expanding Access Through Decentralised Cancer Care
13:00–14:00 CEST	Why Do Patients Still Arrive Late? Fixing Early Diagnosis and Referral in the Community Moderator / chair: Soumen Das Presenter: Soumen Das (India; local: 16:30–17:30 IST) Presenter: Deepak Paudel (Nepal; local: 16:45–17:45 +0545) Patient advocate / navigation perspective: Benda Kithaka (Kenya; local: 14:00–15:00 EAT)
14:00–14:10/14:15 CEST	Approved but Unavailable: Can Biosimilars and Smarter Procurement Close the Essential Medicines Gap? Format: Pre-recorded standalone presentation Presenter: Irene Chidothe-Chisale — Ensuring Reliable Access to Essential Cancer Medicines
15:00–16:00 CEST	Delivering Modern Cancer Therapies in Community Oncology: Building Expertise and Infrastructure Moderator / chair: Fernando Maciel Barbosaf Presenter: Melissa Johnson (USA, Tennessee; local: 08:00–09:00 CDT) — Delivering Modern Therapeutics in Community Oncology: What Can Be Done Safely Today? Presenter: Alice Indini (Italy; local: 15:00–16:00 CEST) — Managing Toxicities Beyond the Academic Centre Presenter: Brooke Peters — Building the Infrastructure for Safe Community Delivery
16:00–17:00 CEST	From Test to Treatment: Closing the Diagnostic Gap in Community Oncology Moderator / chair: Mohana Murali Kolluri Presenter: Nicola Fusco (Italy; local: 16:00–17:00 CEST) — Optimising Molecular Diagnostics in Community Oncology Presenter: Brian Grieb — Reducing Turnaround Time: Building Efficient Diagnostic Pathways Presenter: Glenn Balasky (USA, Colorado; local: 08:00–09:00 MDT) — Who Pays for Precision Oncology? Sustainable Models for Diagnostic Access Additional panellist: Jasmine Kamboj
17:00–18:00 CEST	Community Oncology Across the Americas: Shared Challenges, Shared Solutions Moderator / chair: Allen Chen Presenter: Debra Patt (USA, Texas; local: 10:00–11:00 CDT) — Keynote — Community Oncology in North America: Innovation, Networks and Value-Based Care Presenter: Sergio Contreras Garduño (Mexico; local: 09:00–10:00 CST) — Community Oncology in Latin America: Delivering Care Across Diverse Health Systems Presenter: Carlos Barrios (Brazil; local: 12:00–13:00 -03) — Building Stronger Community Oncology Across the Americas Additional panellist: Roupen Odabashian Health-system and reimbursement expert: Glenn Balasky (USA, Colorado; local: 09:00–10:00 MDT) Additional panellist: Fernando Maciel Barbosa Session topics: • Which elements of the North American community oncology model can realistically be adapted to Latin American health systems? • How can countries reduce disparities in access to diagnostics, medicines, and specialised cancer care? • What role should community oncology play in clinical research, quality improvement, and innovation across the region? • How can stronger collaboration between North and Latin America improve patient outcomes? • What should be the top regional priorities for community oncology over the next five years?
18:00–18:45 CEST	Expanding Biomarker Access in Community Practice Moderator / chair: Melissa Johnson Presenter: Allen Chen (USA, California; local: 09:00–09:45 PDT) — Innovations in Biomarker Testing for Community Oncology Presenter: Benjamin Bleiberg (USA, Pennsylvania; local: 12:00–12:45 EDT) — Optimising the Biomarker Testing Pathway Presenter: Fernando Maciel Barbosa (USA, Iowa; local: 11:00–11:45 CDT) — Partnerships to Expand Access to Precision Medicine Presenter: Terri Conneran — Right Information, Right Time: Sharing Biomarker Results With Patients
18:45–19:45 CEST	Setting Priorities for the Future of Community Oncology Moderator / chair: Debra Patt Presenter: Roupen Odabashian — The Greatest System-Level Barriers in Community Oncology Presenter: Jasmine Kamboj (USA, Minnesota; local: 11:45–12:45 CDT) — From Discussion to Action: Building a Global Community Oncology Agenda
19:45–20:00 CEST	Daily Synthesis and Day 2 Preview Session topics: • Scientific moderators summarise the day in five points, announce the outcome of the barrier vote, and set up the disease-focused programme on Day
	Day 2 \| Saturday, August 29, 2026 \| Central European Summer Time (CEST, UTC+2)
08:00–08:45 CEST	Disease-Focused Practice, Care Delivery and Technology Genitourinary Cancers in Community Practice: Modern Systemic Therapy Across GU Malignancies Moderator / chair: Hasan Dogo Presenter: Jose W. Avitia — Modern Prostate Cancer Care in Community Practice Presenter: Ilya Tsimafeyeu (Russia; local: 09:00–10:00 MSK) — Bladder Cancer: Integrating ADCs, Immunotherapy and Targeted Therapy
09:00–10:00 CEST	Multidisciplinary Decision-Making in Community Oncology: Building Effective Teams Moderator / chair: Abena Yeboah Aduse-Poku Presenter: Abena Yeboah Aduse-Poku (Ghana; local: 07:00–08:00 GMT) — Building Effective Multidisciplinary Teams in Community Oncology Presenter: Debanjan Kundu (India; local: 12:30–13:30 IST) — Digital Innovation and Regional Networks for Multidisciplinary Care Presenter: Jesse Lopes Da Silva — Presentation 3 the importance of diverse teams in both clinical research and oncology care delivery as a strategy to increase the representation of minoritized populations in cancer research and to improve the quality, equity, and cultural responsiveness of oncology care. Presenter: Kseniia Bolharina — Presentation 4 - The oncoHUB Ecosystem, Building a Multidisciplinary Oncology Community and Empowering Young Leaders in Ukraine Additional panellist: Janet Abrahm
10:00–10:45 CEST	Hepatobiliary, Pancreatic and Neuroendocrine Cancers in Community Oncology Moderator / chair: Martina Carullo Presenter: Noha Rashad (Egypt; local: 11:00–12:00 EEST) — Precision Oncology in Hepatobiliary and Pancreatic Cancers Presenter: Josué Jonathan Bravo Espinoza (Peru; local: 03:00–04:00 -05) — Pre-recorded presentation recommended; live discussion participation requires confirmation — Modern Systemic Therapy Across Hepatobiliary, Pancreatic and Neuroendocrine Cancers Session topics: • Building Multidisciplinary Care and Referral Networks Around Minimal-Access Pancreatic Surgery
11:00– 12:00 CEST	Colorectal and Upper GI Cancers in Community Oncology: Biomarker-Guided Treatment and Modern Systemic Therapy Moderator / chair: Josué Jonathan Bravo Espinoza Presenter: Jeanine Frances Ewing (USA, Florida; local: 05:00–06:00 EDT) — Pre-recorded presentation recommended; live discussion participation requires confirmation — Essential Biomarker Testing in Colorectal and Upper GI Cancers Presenter: Martina Carullo (Italy; local: 11:00–12:00 CEST) — Modern Systemic Therapy for Colorectal and Upper GI Cancers Presenter: Darshil Shah (USA, Arizona; local: 02:00–03:00 MST) — Pre-recorded presentation recommended; live discussion participation requires confirmation — Building Multidisciplinary Care for Upper and Lower GI Cancers GI oncology and LMIC clinical perspective: Noha Rashad (Egypt; local: 12:00–13:00 EEST)
12:15–13:15 CEST	Breast Cancer in Community Oncology: Optimising Endocrine Therapy, CDK4/6 Inhibitors and ADCs Moderator / chair: Wajeeha Aiman Presenter: Seema Harichand-Herdt (USA, Iowa; local: 05:15–06:15 CDT) — Very early live slot; pre-recording should be offered — Optimising Treatment Sequencing in Early and Metastatic Breast Cancer Presenter: Houda Belfkih (Tunisia; local: 11:15–12:15 CET) — Biomarker-Guided Breast Cancer Care in Community Practice Presenter: Sana Al-Sukhun — Presentation 3 - Breast Cancer Priorities in limited resource settings Additional panellist: Karez Sarbast Namiq Additional panellist: Jeanine Frances Ewing
13:15–14:00 CEST	Lung Cancer in Community Oncology: Optimising Biomarker Testing, Targeted Therapy and Immunotherapy Moderator / chair: To be confirmed Presenter: Pranshu Bansal (USA, Arizona; local: 04:15–05:15 MST) — Very early live slot; pre-recording should be offered — Optimising Biomarker Testing in Community Lung Cancer Care — Community thoracic oncologist with molecular-testing and targeted-therapy expertise
14:15–15:00 CEST	ICOS Cardio-Oncology Session Session topics: • A dedicated ICOS cardio-oncology session. The detailed session framework, faculty assignments and presentation topics will be added following ICOS coordination and leadership confirmation.
15:00–15:45 CEST	Remote Monitoring, ePROs and Telehealth: What Has Truly Changed Community Oncology? Format: Standalone lecture Presenter: Ruiling Yuan (USA, South Carolina; local: 09:00–09:45 EDT) — Remote Monitoring and ePROs: Improving Patient Outcomes Beyond the Clinic
16:00–16:45 CEST	Clinical Research in Community Oncology: Expanding Access to Innovation Moderator / chair: Adedayo Joseph Presenter: Gustavo Fonseca (USA, Florida; local: 10:00–11:00 EDT) — Building a Clinical Research Programme in Community Oncology Presenter: Adedayo Joseph (Nigeria; local: 15:00–16:00 WAT) — The Research Team: Building Capacity Beyond the Investigator Additional panellist: Jack O. Hensold Rural/community trial access and disease-specialised research: Jose W. Avitia (USA, New Mexico; local: 08:00–09:00 MDT)
17:00–18:00 CEST	Older Adults in Community Oncology: Personalising Cancer Care Beyond Chronological Age Moderator / chair: Houda Belfkih (Tunisia; local: 16:00–17:00 CET) — Profile: Medical oncologist with a submitted focus on practical geriatric assessment Presenter: Esther G. Chong (USA, Oregon; local: 08:00–09:00 PDT) — Comprehensive Geriatric Assessment in Community Oncology Presenter: Viviane Primo Basílio de Souza (Brazil; local: 12:00–13:00 -03) — Current affiliation should be confirmed before publication — Personalising Systemic Therapy for Older Adults Presenter: Janet Abrahm (USA, Massachusetts; local: 11:00–12:00 EDT) — The role of Supportive Oncology in Multidisciplinary Care for Older Adults with Cancer Oncology nursing and APP perspective: Katherine “Katie” Alexander (USA, Ohio; local: 11:00–12:00 EDT) Additional panellist: Ruiling Yuan
18:00–19:00 CEST	AI in Community Oncology: From Clinical Decision Support to Workflow Transformation Moderator / chair: Arturo Loaiza-Bonilla Presenter: Fredrick Dale Ashbury (USA, Colorado; local: 10:00–11:00 MDT) — AI as a Clinical Decision Support Tool in Community Oncology Presenter: Vinona Bhatia (USA, California; local: 09:00–10:00 PDT) — AI in Community Oncology: A Diligence Framework for Clinical Decision Support and Workflow Tools Presenter: Iyad Sultan (Jordan; local: 19:00–20:00 +03) — Building Trust in AI: Medical Data, Validation and Clinical Governance Presenter: Nadia Znassi — Otaska AI co-founder, she will be speaking on decentralizng and sharing private patient data between hospitals across the world, title of her talk: Breaking Borders, Protecting Privacy: Deploying Decentralized AI Networks to Unify Global Cancer Registries — Osaka AI talk AI and radiomics in high-volume public-sector oncology: Debanjan Kundu (India; local: 21:30–22:30 IST) Patient-controlled data and patient perspective: Darshil Shah
19:00–20:00 CEST	Haematologic Malignancies in Community Practice: Referral, Co-Management and Modern Therapies Presenter: Marc Braunstein (USA, New York; local: 13:00–14:00 EDT) — This slot matches the submitted preference for the afternoon of August 29–30 ET — Modern Systemic Therapy for Haematologic Malignancies in Community Practice Presenter: Wajeeha Aiman (USA, New York; local: 13:00–14:00 EDT) — Building Effective Referral and Shared-Care Models for Advanced Haematology Therapies Presenter: Astha Thakkar — Starting bispecific antibody therapy in the community setting Additional panellist: Seema Harichand-Herdt
20:00–20:55 CEST	Clinical Guidelines in Community Oncology: Bridging Evidence and Real-World Practice Moderator / chair: To be confirmed Presenter: Otávio De Carvalho Modaffar Al-alam — From Evidence to Practice: Implementing Clinical Guidelines in Community Oncology Presenter: Jack O. Hensold (USA, Montana; local: 12:00–12:55 MDT) — Tele-Oncology, Decentralized Trials, and Team-Based Care: Making Breast Cancer Guidelines Work in Rural Settings Additional panellist: Fredrick Dale Ashbury
20:55–21:00 CEST	Closing Remarks Proposed closing speaker: Felipe Roitberg (Brazil; local: 15:55–16:00 -03) — Profile: Congress co-chair Session topics: • A brief summary of Day 2’s practical takeaways and the role of community oncology in delivering evidence-based, patient-centred cancer care across diverse settings.
	Day 3 \| Sunday, August 30, 2026 \| Central European Summer Time (CEST, UTC+2) People, Practice and the Future
08:00–09:00 CEST	Improving Access to Cancer Care: Financial Navigation and Affordability Support Moderator / chair: Kashyap Patel Community oncologist from a resource-constrained system: Rajani Jha (Nepal; local: 11:45–12:45 +0545) Cancer-control, public-health and policy perspective: Hadi Mohamad Abu Rasheed Felipe Roitberg Discussion themes: • Identifying and supporting patients experiencing financial toxicity. • Financial navigation beyond medicines: transport, diagnostics, supportive care and indirect costs. • Making patient-assistance and reimbursement pathways easier to understand and use. • Roles for healthcare providers, governments, industry and nongovernmental organisations. • Practical strategies community centres can implement to reduce affordability barriers.
10:00–11:00 CEST	Delivering Equitable Cancer Care: Reaching Underserved Communities Moderator / chair: Angelina Lorello Rural / remote community oncologist: Lara Briseño Kenney (New Zealand; local: 20:00–21:00 NZST) — Evening panel; confirm availability Paediatric haemato-oncologist / health-systems perspective: Irene Mbinya Nzamu Telehealth / outreach programme perspective: Van Tuat Huynh (Vietnam; local: 15:00–16:00 +07) Community-oncology and health-systems perspective: Felipe Roitberg Haematology specialist / underserved-care perspective: Ala Ebaid Discussion themes: • Populations that remain most underserved and the structural reasons for the gap. • Rural, remote and resource-limited delivery models. • Care for older adults, frail patients and people with multiple comorbidities. • Mobile services, outreach programmes, satellite clinics and telehealth. • Community partnerships that reduce socioeconomic and geographic barriers.
11:00–12:00 CEST	Patient Navigation in Community Oncology: Improving Access, Coordination and Outcomes Moderator / chair: Devika Das Navigation / patient-support programme lead: Korede Akindele (Nigeria; local: 10:00–11:00 WAT) Community clinician working across constrained pathways: Ahmed H. Abdelaziz (Egypt; local: 12:00–13:00 EEST) Patient-advocacy and navigation perspective: Martha Raymond Patient navigation, improving access to care, and reducing the burden on patients throughout their cancer journey: Hadi Abu Rasheed (Qatar) — Patient navigation, improving access to care, and reducing the burden on patients throughout their cancer journey Discussion themes: • Functions of a patient navigator and where navigation has the greatest impact. • Coordination among clinicians, nurses, pharmacists, social workers and community organisations. • Supporting oral-therapy adherence and identifying risk of interruption. • Preventing loss to follow-up across referral and treatment transitions. • Using digital navigation to support, rather than replace, human navigation.
13:15–14:15 CEST	Beyond Treatment: Integrating Supportive, Palliative and Survivorship Care into Community Oncology Moderator / chair: To be confirmed Psycho-oncology / psychosocial-support perspective: Adrian Pogacian (Romania; local: 14:15–15:15 EEST) Karez Sarbast Namiq Psycho-oncology / counselling perspective: Vijay C (India; local: 16:45–17:45 IST) — Full name and current affiliation should be confirmed before publication Community oncologist / survivorship perspective: Anjali Sibley Muna Al-Khaifi Psychosocial: Terisa Tamang Discussion themes: • Embedding early supportive and palliative care in routine oncology practice. • Strengthening survivorship transitions between oncology and primary care. • Psychosocial support for patients, families and caregivers. • Practical symptom-management models for community clinics. • Long-term survivorship needs, communication and scan-related anxiety
14:15–15:15 CEST	Leading Community Cancer Centres: Building the Next Generation of Oncology Leaders Moderator / chair: Brian Grieb Community oncologist and clinical-research leader: Brian Grieb Community medical oncologist with leadership responsibilities: Jasmine Kamboj (USA, Minnesota; local: 07:15–08:15 CDT) Quality and patient-safety / care-delivery leader: Brian Bourbeau (USA, Virginia; local: 08:15–09:15 EDT) Community medical oncologist and scientific leader: Joanna Metzner-Sadurski Early-career oncology leader: Ruby Arora (USA, Illinois; local: 07:15–08:15 CDT) Kathy Oubre Discussion themes: • How community-oncology leadership differs from academic-center leadership. • Preparing clinicians for operational, financial and strategic responsibility. • Developing future leaders and resilient multidisciplinary teams. • Leading organisational change while maintaining quality and engagement. • Leadership capabilities needed over the next decade.
15:15–16:00 CEST	Partnering with Patients: Co-Designing Community Cancer Services Format: Conversation Caregiver / patient-experience advocate: Angelina Lorello (USA, New York; local: 09:15–10:00 EDT) Community oncologist leading patient-partnership initiatives: Anjali Sibley (USA, California; local: 06:15–07:00 PDT) Session topics: • Defining meaningful patient partnership. • Patient and caregiver involvement in service design and quality improvement. • Building effective patient advisory groups. • Health literacy, shared decision-making and empowerment. • Transparent and sustainable patient advocacy. Moderator / chair: Brian Grieb Community oncologist and clinical-research leader: Brian Grieb Community medical oncologist with leadership responsibilities: Jasmine Kamboj (USA, Minnesota; local: 07:15–08:15 CDT) Quality and patient-safety / care-delivery leader: Brian Bourbeau (USA, Virginia; local: 08:15–09:15 EDT) Community medical oncologist and scientific leader: Joanna Metzner-Sadurski Early-career oncology leader: Ruby Arora (USA, Illinois; local: 07:15–08:15 CDT) Kathy Oubre Discussion themes: • How community-oncology leadership differs from academic-center leadership. • Preparing clinicians for operational, financial and strategic responsibility. • Developing future leaders and resilient multidisciplinary teams. • Leading organisational change while maintaining quality and engagement. • Leadership capabilities needed over the next decade.
16:00–17:00 CEST	Value-Based Cancer Care and Real-World Evidence: Measuring Outcomes That Matter Moderator / chair: Brian Bourbeau (USA, Virginia; local: 10:00–11:00 EDT) — Profile: ASCO care-delivery leader with community-oncology and quality-improvement expertise Community oncologist experienced in value-based care: Kashyap Patel (USA, South Carolina; local: 10:00–11:00 EDT) Haematology, cellular-therapy and access perspective: Zaid Abdel Rahman Community GU oncologist / real-world evidence perspective: Jahan Aghalar Community oncology / implementation-science perspective: Jonathan Ticku Breast surgical oncology / patient-centred value-based care perspective: Zacharoula Sidiropulou Discussion themes: • Defining and measuring value in community oncology. • Quality indicators that improve outcomes versus those that add burden. • Using real-world evidence in clinical and operational decisions. • Support practices need to participate in value-based models. • Implementation science and the future of sustainable community oncology.
17:00–18:00 CEST	What Community Oncology Needs from Industry: Building Better Partnerships Moderator / chair: Zaid Abdel Rahman Community oncologist, independent practice: Raghad Abdul-Karim (USA, Texas; local: 10:00–11:00 CDT) Community oncologist, resource-limited public system: Sudharshan Gupta (India; local: 20:30–21:30 IST) Practice administrator: Alti Rahman (USA) Oncology pharmacist: Christine Pfaff (USA, Ohio; local: 11:00–12:00 EDT) Discussion themes: • Support community practices need most from industry. • Educational, diagnostic and patient-service initiatives that create meaningful value. • Making access programmes, testing initiatives and grants practical and sustainable. • Barriers to transparent, ethical collaboration. • Opportunities for ongoing forums beyond individual congresses.
18:00–18:45 CEST	Community Oncology in Action: Successful Initiatives from Around the World Moderator / chair: Hannatu Ayuba Spotlight presenter and discussion panellist: Amitabh Ray (India; local: 21:30–22:15 IST) Implementation spotlight presenter and discussion panellist: Parvez Alam Discussion themes: • Spotlight 1 - Scaling Innovation in Community Oncology • Spotlight 2 - Building a Successful Community Oncology Programme • Characteristics of successful community-oncology initiatives. • Adapting programmes across institutions and healthcare systems. • Implementation and sustainability barriers. • Measuring outcomes and impact. • Practical advice for centres beginning similar work.
18:45–19:45 CEST	Community Oncology 2030: Building the Future Together Moderator / chair: Joanna Metzner-Sadurski (USA, South Carolina; local: 12:45–13:45 EDT) — Profile: Congress co-chair and scientific-leadership representative, with OncoDaily leadership Community-oncology strategy and operations perspective: Alti Rahman Congress scientific-leadership seat: Jasmine Kamboj (USA, Minnesota; local: 11:45–12:45 CDT) Piotr Rutkowski Joanna Metzner-Sadurski Mark Walshauser Discussion themes: • Highest priorities for community oncology through 2030. • Challenges requiring urgent collaborative action. • Partnerships among professionals, patients, policymakers and industry. • How progress should be measured before the next congress. • Commitments, next steps and priorities for future congress editions.
19:45–20:00 CEST	Closing Remarks and Next Steps Congress President: Jasmine Kamboj (USA, Minnesota; local: 12:45–13:00 CDT) — Profile: Congress president Scientific leadership representative: Joanna Metzner-Sadurski (USA, South Carolina; local: 13:45–14:00 EDT) — Profile: Congress co-chair OncoDaily Leadership: Representative to be designated by OncoDaily Session topics: • Congress leadership will summarise the major outcomes, outline post-congress dissemination and collaboration, recognise faculty and partners, and formally close the congress.